Role and place of causality assessment
- 1 September 1992
- journal article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 1 (5) , 225-234
- https://doi.org/10.1002/pds.2630010505
Abstract
For biological reasons a drug has either caused or contributed to the development of an adverse reaction or it has not. All intermediary evaluations like possible, probable, etc. are only approximations of the unknown truth. Three practical approaches to assessment are possible — unstructured, based solely on knowledge and experience; semi‐structured, based on certain descriptive criteria; and standardized, based on an operational logic. Nowadays, causality assessment is understood as one of the signaling and sorting parameters and the many drug regulatory agencies assess causality, although rarely using a standardized assessment. The globalization of drug monitoring efforts speaks for a wider acceptance of one method as it would help to understand better how and why a particular assessment was reached.Keywords
This publication has 7 references indexed in Scilit:
- APWI: Past and PresentDrug Information Journal, 1991
- Assessment of Causality in Industrial Setting Special Workshop—IndustrialDrug Information Journal, 1984
- Assessment of adverse drug reactions in psychiatric hospitalsEuropean Journal of Clinical Pharmacology, 1984
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981
- An Algorithm for the Operational Assessment of Adverse Drug ReactionsJAMA, 1979
- Judgments of trained observers on adverse drug reactionsClinical Pharmacology & Therapeutics, 1979
- Toward the operational identification of adverse drug reactionsClinical Pharmacology & Therapeutics, 1977